Section Arrow
XLO.NASDAQ
- Xilio Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2026/03/09 10:37 EDT
Regular Hours
Last
 0.54895
+0.01895 (+3.58%)
Day High 
0.56969 
Prev. Close
0.53 
1-M High
0.6058 
Volume 
90.66K 
Bid
0.548
Ask
0.5499
Day Low
0.5301 
Open
0.5345 
1-M Low
0.503 
Market Cap 
38.93M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.54 
20-SMA 0.55 
50-SMA 0.6 
52-W High 1.18 
52-W Low 0.503 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.61/-4.23
Enterprise Value
45.89M
Balance Sheet
Book Value Per Share
-0.11
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.34M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio8.565-0.085-0.98%-- 
QUREuniQure NV16.29+2.05+14.40%-- 
RLMDRelmada Therapeutics5.9201+1.4701+33.04%-- 
IOVAIovance Biotherapeutics5.095-0.04-0.78%-- 
XENEXenon Pharmaceuticals59.81+17.88+42.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.